BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31670572)

  • 1. Indicator for local recurrence of hepatocellular carcinoma after proton beam therapy: analysis of attenuation difference between the irradiated tumor and liver parenchyma on contrast enhancement CT.
    Takahashi H; Sekino Y; Mori K; Okumura T; Nasu K; Fukuda K; Masuoka S; Iizumi T; Hasegawa N; Sakurai H; Minami M
    Br J Radiol; 2020 Jan; 93(1105):20190375. PubMed ID: 31670572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
    Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
    J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
    Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
    J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis.
    Sugahara S; Nakayama H; Fukuda K; Mizumoto M; Tokita M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tsuboi K; Tokuuye K
    Strahlenther Onkol; 2009 Dec; 185(12):782-8. PubMed ID: 20013087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
    Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
    AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton beam therapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus.
    Sekino Y; Okumura T; Fukumitsu N; Iizumi T; Numajiri H; Mizumoto M; Nakai K; Nonaka T; Ishikawa H; Sakurai H
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):711-720. PubMed ID: 31776663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.
    Lee CH; Hung SP; Hong JH; Chang JT; Tsang NM; Chan KM; Tseng JH; Huang SC; Lin SM; Lien JM; Liu NJ; Lin CC; Chen WT; Chen WY; Chen PJ; Huang BS
    PLoS One; 2018; 13(9):e0203854. PubMed ID: 30204800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton beam therapy for hepatocellular carcinoma.
    Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiotherapy-induced arterial hypervascularity of non-tumorous hepatic parenchyma in patients with hepatocellular carcinoma: potential pitfalls in tumor response evaluation on multiphase computed tomography.
    Park MJ; Kim SY; Yoon SM; Kim JH; Park SH; Lee SS; Lee Y; Lee MG
    PLoS One; 2014; 9(2):e90327. PubMed ID: 24587326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver.
    Lee DH; Lee JM; Klotz E; Kim SJ; Kim KW; Han JK; Choi BI
    Korean J Radiol; 2013; 14(1):51-60. PubMed ID: 23323031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging.
    Takamatsu S; Yamamoto K; Maeda Y; Kawamura M; Shibata S; Sato Y; Terashima K; Shimizu Y; Tameshige Y; Sasaki M; Asahi S; Kondou T; Kobayashi S; Matsui O; Gabata T
    PLoS One; 2016; 11(12):e0167155. PubMed ID: 27907063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cone-Beam Computed Tomography Correlates with Conventional Helical Computed Tomography in Evaluation of Lipiodol Accumulation in HCC after Chemoembolization.
    Ishikawa T; Abe S; Hoshii A; Yamada Y; Iiduka A; Nemoto T; Takeda K; Yoshida T
    PLoS One; 2016; 11(1):e0145546. PubMed ID: 26752696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
    Kim SH; Lee WJ; Lim HK; Lim JH
    J Comput Assist Tomogr; 2007; 31(2):198-203. PubMed ID: 17414753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local control by salvage stereotactic body radiotherapy for recurrent/residual hepatocellular carcinoma after other local therapies.
    Kibe Y; Takeda A; Tsurugai Y; Eriguchi T
    Acta Oncol; 2020 Aug; 59(8):888-894. PubMed ID: 32216593
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the outcomes between surgical resection and proton beam therapy for single primary hepatocellular carcinoma.
    Tamura S; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Murayama S; Uesaka K
    Surg Today; 2020 Apr; 50(4):369-378. PubMed ID: 31602531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
    Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
    World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma.
    Fukuda K; Okumura T; Abei M; Fukumitsu N; Ishige K; Mizumoto M; Hasegawa N; Numajiri H; Ohnishi K; Ishikawa H; Tsuboi K; Sakurai H; Hyodo I
    Cancer Sci; 2017 Mar; 108(3):497-503. PubMed ID: 28012214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee SU; Park JW; Kim TH; Kim YJ; Woo SM; Koh YH; Lee WJ; Park SJ; Kim DY; Kim CM
    Strahlenther Onkol; 2014 Sep; 190(9):806-14. PubMed ID: 24589917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
    Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
    J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma.
    Nakamura M; Fukumitsu N; Kamizawa S; Numajiri H; Nemoto Murofushi K; Ohnishi K; Aihara T; Ishikawa H; Okumura T; Tsuboi K; Sakurai H
    J Radiat Res; 2018 Sep; 59(5):632-638. PubMed ID: 30085200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.